Pisters P W, Pachter H L
Memorial Sloan-Kettering Cancer Center, New York, New York.
Ann Surg. 1994 Mar;219(3):225-35. doi: 10.1097/00000658-199403000-00002.
The authors reviewed the experimental evidence, surgical technique, complications, and results of clinical trials evaluating the role of autologous splenic transplantation for splenic trauma.
Splenorrhaphy and nonoperative management of splenic injuries have now become routine aspects in the management of splenic trauma. Unfortunately, not all splenic injuries are readily amenable to conventional spleen-conserving approaches. Heterotopic splenic autotransplantation has been advocated for patients with severe grade IV and V injuries that would otherwise mandate splenectomy. For this subset of patients, splenic salvage by autotransplantation would theoretically preserve the critical role the spleen plays in the host's defense against infection.
The relevant literature relating to experimental or clinical aspects of splenic autotransplantation was identified and reviewed. Data are presented on the experimental evaluation of autogenous splenic transplantation, methods and complications of autotransplantation, choice of anatomic site and autograft size, and results of clinical trials in humans.
The most commonly used technique of autotransplantation in humans involves implanting tissue homogenates or sections of splenic parenchyma into pouches created in the gastrocolic omentum. Most authors have observed evidence of splenic function with normalization of postsplenectomy thrombocytosis, immunoglobulin M levels, and peripheral blood smears. Some degree of immune function of transplanted grafts has been demonstrated with in vivo assays, but the full extent of immunoprotection provided by human splenic autotransplants is currently unknown.
Multiple human and animal studies have established that splenic autotransplantation is a relatively safe and easily performed procedure that results in the return of some hematologic and immunologic parameters to baseline levels. Some aspects of reticuloendothelial function are also preserved. Whether this translates into a real reduction in the morbidity or mortality rates from overwhelming bacterial infection is unknown and requires further investigation.
作者回顾了评估自体脾移植在脾外伤中作用的实验证据、手术技术、并发症及临床试验结果。
脾修补术和脾损伤的非手术治疗现已成为脾外伤治疗的常规方面。不幸的是,并非所有脾损伤都易于采用传统的保脾方法。对于严重的IV级和V级损伤患者,若不进行脾切除术,则提倡进行异位脾自体移植。对于这部分患者,通过自体移植挽救脾脏理论上可保留脾脏在宿主抗感染防御中所起的关键作用。
检索并回顾了与脾自体移植实验或临床方面相关的文献。呈现了自体脾移植的实验评估、自体移植方法及并发症、解剖部位选择和自体移植大小以及人体临床试验结果的数据。
人类最常用的自体移植技术是将组织匀浆或脾实质切片植入胃结肠网膜中创建的袋囊中。大多数作者观察到脾切除术后血小板增多症、免疫球蛋白M水平和外周血涂片恢复正常,提示有脾功能的证据。体内试验已证明移植移植物具有一定程度的免疫功能,但目前尚不清楚人类脾自体移植提供的免疫保护的全部程度。
多项人体和动物研究已证实,脾自体移植是一种相对安全且易于实施的手术,可使一些血液学和免疫学参数恢复至基线水平。网状内皮系统功能的某些方面也得以保留。这是否能真正降低暴发性细菌感染的发病率或死亡率尚不清楚,需要进一步研究。